Therefore, plasma-derived exosome of DLBCLpatients may carry or target other microRNAs (has-miR-29, hsa-miR-155-5p and has-miR-15/16) or otherupstream pathways regulating IFN-γ level in NK cells ofthe DLBCL patients (27). The gene discussed is IFNG; the disease is diffuse large B-cell lymphoma.